American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID‐19 Pandemic: Version 2
Open Access
- 30 July 2020
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatology
- Vol. 72 (9), E1-E12
- https://doi.org/10.1002/art.41437
Abstract
Objective To provide guidance to rheumatology providers on the management of adult rheumatic disease in the context of the coronavirus disease 2019 (COVID ‐19) pandemic. Methods A task force, including 10 rheumatologists and 4 infectious disease specialists from North America, was convened. Clinical questions were collated, and an evidence report was rapidly generated and disseminated. Questions and drafted statements were reviewed and assessed using a modified Delphi process. This included asynchronous anonymous voting by e‐mail and webinars with the entire panel. Task force members voted on agreement with draft statements using a 1–9‐point numerical scoring system, and consensus was determined to be low, moderate, or high based on the dispersion of votes. For approval, median votes were required to meet predefined levels of agreement (median values of 7–9, 4–6, and 1–3 defined as agreement, uncertainty, or disagreement, respectively) with either moderate or high levels of consensus. Results To date, the task force has approved 80 guidance statements: 36 with moderate and 44 with high consensus. These were combined, resulting in 27 final guidance statements. Conclusion These guidance statements are provided to promote optimal care during the current pandemic. However, given the low level of available evidence and the rapidly evolving literature, this guidance is presented as a “living document,” and future updates are anticipated.This publication has 83 references indexed in Scilit:
- GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendationsJournal of Clinical Epidemiology, 2013
- Suppression of Coronavirus Replication by Cyclophilin InhibitorsViruses, 2013
- The risk of infections associated with rheumatoid arthritis, with its comorbidity and treatmentRheumatology, 2012
- Initiation of Tumor Necrosis Factor-α Antagonists and the Risk of Hospitalization for Infection in Patients With Autoimmune DiseasesJama-Journal Of The American Medical Association, 2011
- Cyclosporin A inhibits the replication of diverse coronavirusesJournal of General Virology, 2011
- Treatment benefit or survival of the fittest: what drives the time-dependent decrease in serious infection rates under TNF inhibition and what does this imply for the individual patient?Annals Of The Rheumatic Diseases, 2011
- Utility of mTOR Inhibition in Hematologic MalignanciesThe Oncologist, 2011
- High disease activity is associated with an increased risk of infection in patients with rheumatoid arthritisAnnals Of The Rheumatic Diseases, 2011
- Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated results from the British Society for Rheumatology Biologics Register with special emphasis on risks in the elderlyRheumatology, 2010
- Diabetes and rheumatic diseasesCurrent Opinion in Rheumatology, 2009